{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:16:22Z","timestamp":1792815382945,"version":"4.5.0"},"reference-count":62,"publisher":"American Association for Cancer Research (AACR)","issue":"5","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["19ck0106470h0001"],"award-info":[{"award-number":["19ck0106470h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["15cm0106056h0005"],"award-info":[{"award-number":["15cm0106056h0005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP19cm0106501h0004"],"award-info":[{"award-number":["JP19cm0106501h0004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP16ck0106073h0003"],"award-info":[{"award-number":["JP16ck0106073h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP19ck0106250h0003"],"award-info":[{"award-number":["JP19ck0106250h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["hp160219"],"award-info":[{"award-number":["hp160219"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["hp170227"],"award-info":[{"award-number":["hp170227"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["hp180198"],"award-info":[{"award-number":["hp180198"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["hp190158"],"award-info":[{"award-number":["hp190158"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP15H05909"],"award-info":[{"award-number":["JP15H05909"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP26221308"],"award-info":[{"award-number":["JP26221308"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP19H05656"],"award-info":[{"award-number":["JP19H05656"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["22H02817"],"award-info":[{"award-number":["22H02817"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP19H01053"],"award-info":[{"award-number":["JP19H01053"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Acute erythroid leukemia (AEL) is a unique subtype of acute myeloid leukemia characterized by prominent erythroid proliferation whose molecular basis is poorly understood. To elucidate the underlying mechanism of erythroid proliferation, we analyzed 121 AEL using whole-genome, whole-exome, and\/or targeted-capture sequencing, together with transcriptome analysis of 21 AEL samples. Combining publicly available sequencing data, we found a high frequency of gains and amplifications involving EPOR\/JAK2 in TP53-mutated cases, particularly those having\u00a0&amp;gt;80% erythroblasts designated as pure erythroid leukemia (10\/13). These cases were frequently accompanied by gains and amplifications of ERG\/ETS2 and associated with a very poor prognosis, even compared with other TP53-mutated AEL. In addition to activation of the STAT5 pathway, a common feature across all AEL cases, these AEL cases exhibited enhanced cell proliferation and heme metabolism and often showed high sensitivity to ruxolitinib in vitro and in xenograft models, highlighting a potential role of JAK2 inhibition in therapeutics of AEL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study reveals the major role of gains, amplifications, and mutations of EPOR and JAK2 in the pathogenesis of pure erythroleukemia. Their frequent response to ruxolitinib in patient-derived xenograft and cell culture models highlights a possible therapeutic role of JAK2 inhibition for erythroleukemia with EPOR\/JAK2-involving lesions.<\/jats:p>\n                    <jats:p>This article is highlighted in the In This Issue feature, p. 369<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-21-0192","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T13:44:31Z","timestamp":1657892671000},"page":"410-427","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Amplified\n                    <i>EPOR<\/i>\n                    \/\n                    <i>JAK2<\/i>\n                    Genes Define a Unique Subtype of Acute Erythroid Leukemia"],"prefix":"10.1158","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0729-2344","authenticated-orcid":false,"given":"June","family":"Takeda","sequence":"first","affiliation":[{"name":"1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4612-2778","authenticated-orcid":false,"given":"Kenichi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6420-2555","authenticated-orcid":false,"given":"Masahiro M.","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6526-0992","authenticated-orcid":false,"given":"Yasuhito","family":"Nannya","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."},{"name":"2Division of Hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7806-1909","authenticated-orcid":false,"given":"Akinori","family":"Yoda","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6984-7187","authenticated-orcid":false,"given":"Ryunosuke","family":"Saiki","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-6164","authenticated-orcid":false,"given":"Yotaro","family":"Ochi","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3959-0699","authenticated-orcid":false,"given":"Lanying","family":"Zhao","sequence":"additional","affiliation":[{"name":"3Institute for the Advanced Study of Human Biology (WPI ASHBi), Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7124-4171","authenticated-orcid":false,"given":"Rurika","family":"Okuda","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4908-1457","authenticated-orcid":false,"given":"Xingxing","family":"Qi","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3983-0488","authenticated-orcid":false,"given":"Takuto","family":"Mori","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7237-0180","authenticated-orcid":false,"given":"Ayana","family":"Kon","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9439-6998","authenticated-orcid":false,"given":"Kenichi","family":"Chiba","sequence":"additional","affiliation":[{"name":"4Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9634-8922","authenticated-orcid":false,"given":"Hiroko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"5M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6144-5845","authenticated-orcid":false,"given":"Yuichi","family":"Shiraishi","sequence":"additional","affiliation":[{"name":"4Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1324-5034","authenticated-orcid":false,"given":"Ming-Chung","family":"Kuo","sequence":"additional","affiliation":[{"name":"6Division of Hematology\u2212Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taoyuan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2174-6560","authenticated-orcid":false,"given":"Cassandra M.","family":"Kerr","sequence":"additional","affiliation":[{"name":"7Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0866-929X","authenticated-orcid":false,"given":"Yasunobu","family":"Nagata","sequence":"additional","affiliation":[{"name":"7Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8200-0391","authenticated-orcid":false,"given":"Daisuke","family":"Morishita","sequence":"additional","affiliation":[{"name":"8Chordia Therapeutics Inc., Kanagawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0472-6680","authenticated-orcid":false,"given":"Nobuhiro","family":"Hiramoto","sequence":"additional","affiliation":[{"name":"9Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6498-4166","authenticated-orcid":false,"given":"Akira","family":"Hangaishi","sequence":"additional","affiliation":[{"name":"10Department of Hematology, NTT Medical Centre Tokyo, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6457-5052","authenticated-orcid":false,"given":"Hideyuki","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"11Department of Hematology, Shinshu University Hospital, Matsumoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6189-0620","authenticated-orcid":false,"given":"Ken","family":"Ishiyama","sequence":"additional","affiliation":[{"name":"12Department of Hematology, Kanazawa University, Kanazawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1753-6616","authenticated-orcid":false,"given":"Satoru","family":"Miyano","sequence":"additional","affiliation":[{"name":"5M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7803-7338","authenticated-orcid":false,"given":"Shigeru","family":"Chiba","sequence":"additional","affiliation":[{"name":"13Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3683-7147","authenticated-orcid":false,"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"14Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan."},{"name":"15Japan Adult Leukemia Study Group, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4194-1638","authenticated-orcid":false,"given":"Toshiyuki","family":"Kitano","sequence":"additional","affiliation":[{"name":"16Department of Hematology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1216-4470","authenticated-orcid":false,"given":"Kensuke","family":"Usuki","sequence":"additional","affiliation":[{"name":"10Department of Hematology, NTT Medical Centre Tokyo, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0453-5657","authenticated-orcid":false,"given":"Nobuo","family":"Sezaki","sequence":"additional","affiliation":[{"name":"17Department of Hematology, Chugoku Central Hospital, Hiroshima, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-5790","authenticated-orcid":false,"given":"Hisashi","family":"Tsurumi","sequence":"additional","affiliation":[{"name":"18Department of Hematology, Gifu University, Gifu, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Miyawaki","sequence":"additional","affiliation":[{"name":"19Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6837-4346","authenticated-orcid":false,"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[{"name":"7Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2098-9616","authenticated-orcid":false,"given":"Takayuki","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"9Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Ohyashiki","sequence":"additional","affiliation":[{"name":"20Department of Hematology, Tokyo Medical University, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3510-4304","authenticated-orcid":false,"given":"Arnold","family":"Ganser","sequence":"additional","affiliation":[{"name":"21Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5318-9044","authenticated-orcid":false,"given":"Michael","family":"Heuser","sequence":"additional","affiliation":[{"name":"21Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5848-6152","authenticated-orcid":false,"given":"Felicitas","family":"Thol","sequence":"additional","affiliation":[{"name":"21Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1866-7922","authenticated-orcid":false,"given":"Lee-Yung","family":"Shih","sequence":"additional","affiliation":[{"name":"6Division of Hematology\u2212Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taoyuan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-4284","authenticated-orcid":false,"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[{"name":"22Department of Hematology\/Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5983-8578","authenticated-orcid":false,"given":"Hideki","family":"Makishima","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7778-5374","authenticated-orcid":false,"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."},{"name":"3Institute for the Advanced Study of Human Biology (WPI ASHBi), Kyoto University, Kyoto, Japan."},{"name":"23Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"2025112416545352800_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1182\/blood.V7.8.765.765","article-title":"Erythremic myelosis (Dl Guglielmo's disease): critical review with report of four cases, and comments on erythroleukemia","volume":"7","author":"Schwartz","year":"1952","journal-title":"Blood"},{"key":"2025112416545352800_bib2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"key":"2025112416545352800_bib3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2141.1995.tb05208.x","article-title":"Minimally differentiated erythroleukaemia (AML M6 \u2018variant\u2019): a rare subset of AML distinct from AML M6. Groupe Francais d'Hematologie Cellulaire","volume":"90","author":"Garand","year":"1995","journal-title":"Br J Haematol"},{"key":"2025112416545352800_bib4","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"2025112416545352800_bib5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"2025112416545352800_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cancergencyto.2005.05.006","article-title":"Cytogenetic study of 75 erythroleukemias","volume":"163","author":"Lessard","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"2025112416545352800_bib7","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"key":"2025112416545352800_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"2025112416545352800_bib9","first-page":"460","article-title":"Di una emopatia sistemizzata rapresentata da una imperplasia eritroblastica (eritronatosis)","volume":"4","author":"Copelli","year":"1912","journal-title":"Pathologica"},{"key":"2025112416545352800_bib10","first-page":"386","article-title":"Richerche di ematologia. I. Un caso di eritroleucemia. Megacariociti in circolo e loro funzione piastrinopoietico","volume":"13","author":"Di Guglielmo","year":"1917","journal-title":"Folia Medica (Pavia)"},{"key":"2025112416545352800_bib11","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"2025112416545352800_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.blre.2017.09.002","article-title":"Erythroleukemia-historical perspectives and recent advances in diagnosis and management","volume":"32","author":"Boddu","year":"2018","journal-title":"Blood Rev"},{"key":"2025112416545352800_bib13","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/leu.2013.144","article-title":"Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics","volume":"27","author":"Grossmann","year":"2013","journal-title":"Leukemia"},{"key":"2025112416545352800_bib14","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/leu.2015.198","article-title":"Molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing","volume":"30","author":"Cervera","year":"2016","journal-title":"Leukemia"},{"key":"2025112416545352800_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/leu.2016.162","article-title":"Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia","volume":"31","author":"Ping","year":"2017","journal-title":"Leukemia"},{"key":"2025112416545352800_bib16","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1182\/blood-2016-11-749903","article-title":"More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia","volume":"129","author":"Montalban-Bravo","year":"2017","journal-title":"Blood"},{"key":"2025112416545352800_bib17","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1038\/bcj.2017.68","article-title":"Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification","volume":"7","author":"Cervera","year":"2017","journal-title":"Blood Cancer J"},{"key":"2025112416545352800_bib18","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41588-019-0375-1","article-title":"Genomic subtyping and therapeutic targeting of acute erythroleukemia","volume":"51","author":"Iacobucci","year":"2019","journal-title":"Nat Genet"},{"key":"2025112416545352800_bib19","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"key":"2025112416545352800_bib20","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/s41591-020-1008-z","article-title":"Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes","volume":"26","author":"Bernard","year":"2020","journal-title":"Nat Med"},{"key":"2025112416545352800_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/modpathol.2010.194","article-title":"Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification","volume":"24","author":"Liu","year":"2011","journal-title":"Mod Pathol"},{"key":"2025112416545352800_bib22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2159-8290.CD-19-0125","article-title":"The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells","volume":"9","author":"Nechiporuk","year":"2019","journal-title":"Cancer Discov"},{"key":"2025112416545352800_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-0609.2010.01557.x","article-title":"APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells","volume":"86","author":"Ali","year":"2011","journal-title":"Eur J Haematol"},{"key":"2025112416545352800_bib24","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1182\/blood.2020009103","article-title":"Modeling and targeting of erythroleukemia by hematopoietic genome editing","volume":"137","author":"Iacobucci","year":"2021","journal-title":"Blood"},{"key":"2025112416545352800_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-020-03064-z","article-title":"Chromothripsis drives the evolution of gene amplification in cancer","volume":"591","author":"Shoshani","year":"2021","journal-title":"Nature"},{"key":"2025112416545352800_bib26","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"2025112416545352800_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"},{"key":"2025112416545352800_bib28","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"key":"2025112416545352800_bib29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ng.3742","article-title":"Dynamics of clonal evolution in myelodysplastic syndromes","volume":"49","author":"Makishima","year":"2017","journal-title":"Nat Genet"},{"key":"2025112416545352800_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ccell.2015.12.013","article-title":"Truncating erythropoietin receptor rearrangements in acute lymphoblastic leukemia","volume":"29","author":"Iacobucci","year":"2016","journal-title":"Cancer Cell"},{"key":"2025112416545352800_bib31","doi-asserted-by":"crossref","first-page":"18291","DOI":"10.1016\/S0021-9258(17)32302-5","article-title":"The extended box 2 subdomain of erythropoietin receptor is nonessential for Jak2 activation yet critical for efficient mitogenesis in FDC-ER cells","volume":"269","author":"He","year":"1994","journal-title":"J Biol Chem"},{"key":"2025112416545352800_bib32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1182\/blood-2018-10-844621","article-title":"Genetics of MDS","volume":"133","author":"Ogawa","year":"2019","journal-title":"Blood"},{"key":"2025112416545352800_bib33","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood-2014-11-610543","article-title":"Acute myeloid leukemia ontogeny is defined by distinct somatic mutations","volume":"125","author":"Lindsley","year":"2015","journal-title":"Blood"},{"key":"2025112416545352800_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"2025112416545352800_bib35","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112416545352800_bib36","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1182\/blood-2014-01-548305","article-title":"Global transcriptome analyses of human and murine terminal erythroid differentiation","volume":"123","author":"An","year":"2014","journal-title":"Blood"},{"key":"2025112416545352800_bib37","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"2025112416545352800_bib38","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/sj.leu.2400838","article-title":"Establishment and characterization of a new erythropoietin-dependent acute myeloid leukemia cell line, AS-E2","volume":"11","author":"Miyazaki","year":"1997","journal-title":"Leukemia"},{"key":"2025112416545352800_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood.V73.2.375.375","article-title":"Identification and analysis of human erythropoietin receptors on a factor-dependent cell line, TF-1","volume":"73","author":"Kitamura","year":"1989","journal-title":"Blood"},{"key":"2025112416545352800_bib40","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","article-title":"NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells","volume":"100","author":"Ito","year":"2002","journal-title":"Blood"},{"key":"2025112416545352800_bib41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0092-8674(93)90414-L","article-title":"JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin","volume":"74","author":"Witthuhn","year":"1993","journal-title":"Cell"},{"key":"2025112416545352800_bib42","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood-2012-10-460998","article-title":"Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder","volume":"122","author":"Birger","year":"2013","journal-title":"Blood"},{"key":"2025112416545352800_bib43","doi-asserted-by":"crossref","first-page":"15437","DOI":"10.1073\/pnas.1213454109","article-title":"Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro-megakaryocytic leukemia","volume":"109","author":"Carmichael","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112416545352800_bib44","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1073\/pnas.1304234110","article-title":"Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia","volume":"110","author":"Tang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112416545352800_bib45","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1182\/blood.2019003062","article-title":"Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers","volume":"136","author":"Fagnan","year":"2020","journal-title":"Blood"},{"key":"2025112416545352800_bib46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/sj.leu.2405066","article-title":"The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy","volume":"22","author":"Ge","year":"2008","journal-title":"Leukemia"},{"key":"2025112416545352800_bib47","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1073\/pnas.0400272101","article-title":"Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes","volume":"101","author":"Baldus","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112416545352800_bib48","doi-asserted-by":"crossref","first-page":"E4030","DOI":"10.1073\/pnas.1702489114","article-title":"Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome","volume":"114","author":"Schwartzman","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112416545352800_bib49","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1021\/jacs.5b04284","article-title":"Kinase-independent small-molecule inhibition of JAK-STAT signaling","volume":"137","author":"Chou","year":"2015","journal-title":"J Am Chem Soc"},{"key":"2025112416545352800_bib50","doi-asserted-by":"crossref","first-page":"EVIDoa2200008","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evidence"},{"key":"2025112416545352800_bib51","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1182\/blood-2019-122802","article-title":"Prospective comparison of azacitidine treatment between 7-days and 5-days schedules for patients with higher-risk myelodysplastic syndromes; results of Japan Adult Leukemia Study Group MDS212 Trial","volume":"134","author":"Kiguchi","year":"2019","journal-title":"Blood"},{"key":"2025112416545352800_bib52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"key":"2025112416545352800_bib53","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1093\/nar\/gkt126","article-title":"An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data","volume":"41","author":"Shiraishi","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2025112416545352800_bib54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1913-9","article-title":"Patterns of somatic structural variation in human cancer genomes","volume":"578","author":"Li","year":"2020","journal-title":"Nature"},{"key":"2025112416545352800_bib55","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"key":"2025112416545352800_bib56","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3\u2032-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"key":"2025112416545352800_bib57","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood-2016-12-754796","article-title":"Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation","volume":"129","author":"Yoshizato","year":"2017","journal-title":"Blood"},{"key":"2025112416545352800_bib58","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1038\/s41467-018-06063-x","article-title":"Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia","volume":"9","author":"Shiozawa","year":"2018","journal-title":"Nat Commun"},{"key":"2025112416545352800_bib59","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/bioinformatics\/btq635","article-title":"Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization","volume":"27","author":"Boeva","year":"2011","journal-title":"Bioinformatics"},{"key":"2025112416545352800_bib60","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2025112416545352800_bib61","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccell.2016.03.008","article-title":"The public repository of xenografts enables discovery and randomized phase II-like trials in mice","volume":"29","author":"Townsend","year":"2016","journal-title":"Cancer Cell"},{"key":"2025112416545352800_bib62","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-21-0192\/3180420\/bcd-21-0192.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-21-0192\/3185484\/bcd-21-0192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/3\/5\/410\/3267428\/410.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/3\/5\/410\/3267428\/410.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:55:09Z","timestamp":1764021309000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/3\/5\/410\/708354\/Amplified-EPOR-JAK2-Genes-Define-a-Unique-Subtype"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":62,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,7,14]]},"published-print":{"date-parts":[[2022,9,6]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-21-0192","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2643-3230.22545312.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.c.6550902.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.c.6550902","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.22545315.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2643-3230.22545312","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.22545315","asserted-by":"object"}]},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]}}}